Baxter to obtain Synovis Baxter International Inc.

Baxter to obtain Synovis Baxter International Inc http://www.top-avana.com http://top-avana.com . and Synovis Existence Technology, Inc. today announced a definitive contract for Baxter to obtain Synovis, a leading supplier of biological and mechanical items for soft tissue fix used in a range of surgical procedures. The acquisition complements and can increase the portfolio of Baxter’s regenerative medication and biosurgery franchise, with a number of products and biological items for hemostasis, tissue adherence and sealing. The Synovis panel of directors provides unanimously approved the purchase and is usually recommending that its shareholders approve the contract at an offer cost of $28 per talk about, which compatible $325 million of collateral value or approximately $260 million after adjusting for the web cash.